Aurinia's Lupkynis Shows Treatment Benefit In Lupus Nephritis, Additional Efficacy Data Shows
Aurinia's Stock More Than Doubles On Results From Pivotal Trial Of Voclosporin In Lupus Nephritis
Ongoing Aurinia Pharmaceuticals Study Results Boost Shares Higher
Aurinia Pharma's Phase 2b Data Lifts Stock, Suggests Big Potential